Yu Huang1, Jiarui Chen2, Jin Lin3, Jianhua Lin1, Xuanwei Chen1. 1. Department of Spine Surgery, The First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian 350005, China. 2. Department of Pharmacy, Fujian Medical University, Fuzhou, Fujian 350108, China. 3. Department of Basic Medical Science, Fujian Health College, Fuzhou, Fujian 350101, China.
Abstract
Orthopedic infection is a serious complication in surgeries and remains a great challenge in clinics. Here, the natural antimicrobial compound vanillic acid-loaded gold nanospheres/mesoporous silica nanoparticles (VA@Au-MSNs) were fabricated for chemo-photothermal synergistic therapy to orthopedic infections. The shape and morphology of Au-MSN and VA@Au-MSN were observed by scanning electron microscopy and transmission electron microscopy. The properties of VA@Au-MSN or related components were characterized by dynamic light scattering, thermogravimetric analysis, Brunauer-Emmett-Teller (BET) analysis, and photothermal analysis. Vanillic acid released from VA@Au-MSN was detected in phosphate-buffered saline. A cytotoxicity test and an antibacterial assessment were performed to explore the biosafety and antibacterial activity of VA@Au-MSN, respectively. The results showed that Au-MSN possessed a high BET surface area (458 m2/g). After loading vanillic acid, the BET surface area reduced to 72 m2/g. The loading efficiency of Au-MSN was 18.56%. Under 808 nm laser irradiation, the temperature at the wound site injected with the Au-MSN solution in the mouse increased from 24 to 60 °C within about 12 s. Also, the high temperature could promote the release of vanillic acid from VA@Au-MSN. Additionally, VA@Au-MSN has no obvious cytotoxicity to MC3T3-E1 cells, but the generated local hyperthermia and the VA released from VA@Au-MSN had excellent antibacterial activity against Staphylococcus aureus in a synergistic way. In conclusion, the VA@Au-MSN with biosafety and excellent antibacterial performance might be applied for the treatment of orthopedic infection.
Orthopedic infection is a serious complication in surgeries and remains a great challenge in clinics. Here, the natural antimicrobial compound vanillic acid-loaded gold nanospheres/mesoporous silica nanoparticles (VA@Au-MSNs) were fabricated for chemo-photothermal synergistic therapy to orthopedic infections. The shape and morphology of Au-MSN and VA@Au-MSN were observed by scanning electron microscopy and transmission electron microscopy. The properties of VA@Au-MSN or related components were characterized by dynamic light scattering, thermogravimetric analysis, Brunauer-Emmett-Teller (BET) analysis, and photothermal analysis. Vanillic acid released from VA@Au-MSN was detected in phosphate-buffered saline. A cytotoxicity test and an antibacterial assessment were performed to explore the biosafety and antibacterial activity of VA@Au-MSN, respectively. The results showed that Au-MSN possessed a high BET surface area (458 m2/g). After loading vanillic acid, the BET surface area reduced to 72 m2/g. The loading efficiency of Au-MSN was 18.56%. Under 808 nm laser irradiation, the temperature at the wound site injected with the Au-MSN solution in the mouse increased from 24 to 60 °C within about 12 s. Also, the high temperature could promote the release of vanillic acid from VA@Au-MSN. Additionally, VA@Au-MSN has no obvious cytotoxicity to MC3T3-E1 cells, but the generated local hyperthermia and the VA released from VA@Au-MSN had excellent antibacterial activity against Staphylococcus aureus in a synergistic way. In conclusion, the VA@Au-MSN with biosafety and excellent antibacterial performance might be applied for the treatment of orthopedic infection.
Medical
device-associated infection is an extremely serious complication
after orthopedic surgery and remains a challenging and troubling problem
in clinics.[1,2] Antibiotic therapy is a conventional and
widely used approach for orthopedic infection. However, due to the
emergence of antibiotic-resistant strains and the formation of bacterial
biofilms, the control of infection by antibiotics is always a failure.[3,4] Otherwise, antibiotic application contributed to fever in orthopedic
patients.[5] Thus, it is essential and meaningful
to develop novel treatment approaches for the management of orthopedic
infection.Vanillic acid, a natural phenolic compound, can be
extracted from
numerous edible fruits and plants, including Amburana
cearensis AC Smith,[6]Actinidia deliciosa,[7] and Panax ginseng CA Meyer.[8] Stanely et al. disclosed that vanillic acid could protect the rats
against cardiotoxicity induced by isoproterenol due to its anti-inflammatory
and antioxidant properties.[9] In the typical
inflammatory disease—ulcerative colitis, vanillic acid also
had beneficial effects.[10] In addition,
vanillic acid posed excellent antimicrobial effects against several
strains of Listeria spp., including Listeria monocytogenes, which could cause infections
in humans.[11−13] Vanillic acid isolated from kiwifruit is nontoxic
and could impede virulence and infection caused by Serratia marcescens.(7)Purified gold nanoparticles had no detectable cytotoxicity and
immunogenicity and are biocompatible in macrophage cells.[14,15] Gold nanoparticles had been reported to be used for the diagnosis
and therapy of diverse diseases.[16−18] Mesoporous silica nanoparticles
(MSNs) have attracted the attention of most researchers working in
the biomedical domain due to their excellent properties for drug delivery.[19,20] Both gold nanoparticles and MSNs are candidate nanoscale materials
for drug delivery systems.[21,22] For example, MSNs have
been used for integrating chemo-, gene- and photothermal substances
to prepare a multifunctional antitumor nanoplatform.[23,24] Additionally, gold-modified porous silicon nanopillars had excellent
antibacterial performance against S. aureus.(25) In this study, core–shell nanocomposite
Au-MSNs were prepared by coating MSN onto gold nanoparticles. The
natural antimicrobial compound vanillic acid was loaded into Au-MSN,
and the obtained composites were termed VA@Au-MSN. The shape, morphology,
particle size, Brunauer–Emmett–Teller surface area thermogravimetric
property, and drug-loading efficacy of Au-MSN or VA@Au-MSN were detected
according to responding methods. The cytotoxicity of VA@Au-MSN was
determined in MC3T3-E1mouse calvaria-derived cells. A clone formation
assay and a live/dead bacterial observation test were performed to
assess the antibacterial capacity of VA@Au-MSN.
Results
and Discussion
Characterization of Au-MSNs
and VA@Au-MSNs
The scanning electron microscopy (SEM) and
transmission electron
microscopy (TEM) images showed that Au-MSN displayed a uniform spherical
shape with a relatively smooth surface; while after loading vanillic
acid, the surface of VA@Au-MSN was uneven and much rougher (Figure a,b). The diameter
of the fabricated Au-MSN was 101.1 ± 8.5 nm (Figure c). N2 adsorption–desorption
isotherms of Au-MSN presented a typical type-IV isotherm, which exhibited
a mesoporous property[26] (Figure d). The BET surface area and
pore size of Au-MSN were 458 m2/g and 2.65 nm, respectively,
which were consistent with those of MSN.[27] MSN has been reported to have high drug-loading efficiency.[28,29] Herein, after loading vanillic acid, the BET surface area of VA@Au-MSN
reduced to 72 m2/g and the diameter of VA@Au-MSN increased
to 116.7 ± 9.2 nm. The TGA analysis showed that the loading efficiency
of Au-MSN was 18.56% (Figure e).
Figure 1
Characterization of Au-MSN and VA@Au-MSN. Representative SEM and
TEM images of Au-MSN (a) and VA@Au-MSN (b). Particle sizes (c) and
N2 adsorption–desorption isotherms (d) for Au-MSN
and VA@Au-MSN. (e) TGA curves recorded for VA, Au-MSN, and VA@Au-MSN.
Au-MSN, gold-plated mesoporous silica nanoparticles; VA@Au-MSN, vanillic
acid-loaded Au-MSN.
Characterization of Au-MSN and VA@Au-MSN. Representative SEM and
TEM images of Au-MSN (a) and VA@Au-MSN (b). Particle sizes (c) and
N2 adsorption–desorption isotherms (d) for Au-MSN
and VA@Au-MSN. (e) TGA curves recorded for VA, Au-MSN, and VA@Au-MSN.
Au-MSN, gold-plated mesoporous silica nanoparticles; VA@Au-MSN, vanillic
acid-loaded Au-MSN.The heat conversion capacity
of Au-MSN was assessed by a photothermal
effect assay. As shown in Figure a,b, the temperature of the Au@MSN suspension could
increase rapidly up to about 60 °C within 40 s under NIR 808
nm laser irradiation at a power density of 1.0 W/cm2 in
vitro. The local temperature at the site injected with the Au-MSN
solution in the mouse increased from 24 to 60 °C after 12 s of
irradiation by the NIR 808 nm laser light (Figure c). The results indicated the great heat
conversion capacity of Au-MSN and were consistent with Zhao et al.’s
report that gold nanorod-loaded-multicompartment MSNs produced hyperthermia
under NIR irradiation.[30]
Figure 2
Photothermal effect was
assessed in vitro and in vivo. (a) Images
of the temperature change under 808 nm NIR irradiation in vitro and
in vivo. Temperature curves of Au-MSN under 808 nm NIR irradiation
in vitro (b) and in vivo (c).
Photothermal effect was
assessed in vitro and in vivo. (a) Images
of the temperature change under 808 nm NIR irradiation in vitro and
in vivo. Temperature curves of Au-MSN under 808 nm NIR irradiation
in vitro (b) and in vivo (c).
Measurement of Vanillic Acid Release
To
determine the effects of temperature on the release performance
of vanillic acid from VA@Au-MSN, vanillic acid release assays were
performed at different temperatures. After 72 h of incubation, the
cumulative release rate of vanillic acid from VA@Au-MSN was 78.95
± 1.41% at 42 °C, while the release rate was 42.61 ±
1.71% at 37 °C (Figure ). The amount of vanillic acid released from VA@Au-MSN at
42 °C was significantly higher than that at 37 °C. These
findings revealed the highly effective vanillic acid release triggered
by the temperature.
Figure 3
Vanillic acid release curves from VA@Au-MSN at 37 and
42 °C.
Vanillic acid release curves from VA@Au-MSN at 37 and
42 °C.
Cytotoxicity
of VA@Au-MSNs in MC3T3-E1 Cells
To investigate the cytotoxicity
of Au-MSN and VA@Au-MSN in MC3T3-E1
cells, MC3T3-E1 cells were incubated with Au-MSN or VA@Au-MSN and
the growth of the cells was observed by CLSM. After 24 h of incubation,
there was no significant difference in the nuclear morphology and
cell number of MC3T3-E1 cells among the control group, the group incubated
with Au-MSN, and the group incubated with VA@Au-MSN (Figure ). After treating with Au-MSN
or VA@Au-MSN, the cell viability was more than 85% even at a concentration
of 0.5 mg/mL. All of these results indicated that Au-MSN and VA@Au-MSN
had no obvious cytotoxicity to MC3T3-E1 cells and suggested its biosafety
in the biological application of VA@Au-MSN for orthopedic infections.
Figure 4
Cytotoxicity
of Au-MSN and VA@Au-MSN to MC3T3-E1 cells. (a) Confocal
laser scanning microscopy observations of MC3T3-E1 cells incubated
with Au-MSN or VA@Au-MSN for 24 h. For each panel, the images from
left to right represented cell nuclei (blue fluorescence) stained
with DAPI, F-actin (green fluorescence) stained with FITC, and the
merged images of the left two. (b) Cell viability of MC3T3-E1 cells
incubated with different concentrations of Au-MSN or VA@Au-MSN for
24 h.
Cytotoxicity
of Au-MSN and VA@Au-MSN to MC3T3-E1 cells. (a) Confocal
laser scanning microscopy observations of MC3T3-E1 cells incubated
with Au-MSN or VA@Au-MSN for 24 h. For each panel, the images from
left to right represented cell nuclei (blue fluorescence) stained
with DAPI, F-actin (green fluorescence) stained with FITC, and the
merged images of the left two. (b) Cell viability of MC3T3-E1 cells
incubated with different concentrations of Au-MSN or VA@Au-MSN for
24 h.
Antibacterial
Potential of VA@Au-MSNs
As the most common causative pathogen
of orthopedic and device-related
infections, Staphylococcus aureus (S. aureus) has been widely used in research studies
for orthopedic infections.[31,32] Thus, the antibacterial
potential of VA@Au-MSN was assessed by coculturing with S. aureus here. Compared with the control group and
the group cocultured with Au-MSN, VA@Au-MSN and VA@Au-MSN + NIR groups
had a significantly lower number of colony-forming units (Figures a and S1). Moreover, fewer colony-forming units obviously
appeared in the VA@Au-MSN + NIR group than in the VA@Au-MSN group,
suggesting NIR had a synergistic effect against the bacterial growth.
Figure 5
Antibacterial
performance assessment of VA@Au-MSN against Staphylococcus
aureus. (a) Antibacterial potential
of Au-MSN and VA@Au-MSN with and without 808 nm NIR irradiation was
assessed by the colony-forming assay. (b) Live (green fluorescence)
and dead (red fluorescence) bacteria-incubated Au-MSN or VA@Au-MSN
with and without 808 nm NIR irradiation. The scale bar is 50 μm.
Antibacterial
performance assessment of VA@Au-MSN against Staphylococcus
aureus. (a) Antibacterial potential
of Au-MSN and VA@Au-MSN with and without 808 nm NIR irradiation was
assessed by the colony-forming assay. (b) Live (green fluorescence)
and dead (red fluorescence) bacteria-incubated Au-MSN or VA@Au-MSN
with and without 808 nm NIR irradiation. The scale bar is 50 μm.As shown in Figure b, the control group and the group cocultured with
Au-MSN had a large
number of live bacteria (green fluorescence) and a few dead bacteria
(red fluorescence), suggesting no antibacterial performance. VA@Au-MSN
and VA@Au-MSN + NIR groups had a markedly reduced number of live bacteria
and an increased number of dead bacteria. Additionally, the VA@Au-MSN
+ NIR group had fewer live bacteria and more dead bacteria than the
VA@Au-MSN group. The results were consistent with those of the colony
formation assay. NIR light irradiation could not only promote the
release of antibacterial drugs from the thermosensitive hydrogel-based
drug reservoir, but the resulting local hyperthermia induced the destruction
of bacterial integrity.[33] Here, the generated
local hyperthermia by the nanoparticles under NIR irradiation accelerated
the release of VA, which blocked quorum sensing and thus inhibited
biofilm production and bacterial virulence.[7] Finally, VA and the local hyperthermia exerted antibacterial effects
in a synergistic way.
Conclusions
In conclusion,
the core–shell gold nanospheres/mesoporoussilica nanoparticles (Au-MSNs), which had great heat conversion capacity
and high drug-loading property, were prepared by coating MSN onto
gold nanospheres. Higher temperatures promoted vanillic acid release
from vanillic acid-loaded Au-MSN (VA@Au-MSN), which had no detectable
cytotoxicity to MC3T3-E1mouse calvaria-derived cells. Notably, VA
released from VA@Au-MSN and the local hyperthermia under NIR irradiation
had excellent antibacterial activity against Staphylococcus
aureus in a synergistic way. Therefore, VA@Au-MSN
might be used for chemo-photothermal therapy of orthopedic infections.
Materials and Methods
Preparation of Au-MSNs
and Vanillic Acid-Loaded-Au-MSNs
Au-MSNs were fabricated
according to the reported method.[34,35] First, 1.5
mL of cetyltrimethylammonium bromide (CTAB, 0.2 M) and
5 mL of chloroauric acid (HAuCl4·4H2O,
0.05 mM) were mixed. After adding 0.6 mL of NaBH4 (0.01
M), the above solution was stirred for 3 min and maintained at 25
°C for 2 h. The obtained standby solution was stored for usage
in the following steps. Second, 200 mL of CTAB (0.1 M), 10 mL of HAuCl4·4H2O (0.01 M), and 2 mL of AgNO3 (0.01 M) were mixed. After 3 min of reaction, the solution was supplied
with 1.6 mL of ascorbic acid (17.6 mg/mL) and stirred for 5 s. Then,
4 mL of H2SO4 solution was added to the above
mixture followed by 30 min of reaction. In the end, the reaction mixture
and 0.5 mL of the above standby solution were mixed and kept for 12
h at 30 °C to prepare Au nanoparticles.Subsequently, the
Au nanoparticles were dispersed in 15 mL of ultrapure water. NaOH
(150 μL, 0.1 M) was added to the Au nanoparticle solution. Then,
the Au-MSN was prepared by adding 20% tetraethylorthosilicate three
times. Vanillic acid-loaded-Au-MSN (VA@Au-MSN) was fabricated by adding
the prepared Au-MSN to the vanillic acid solution.
Characterization of Au-MSNs and VA@Au-MSNs
Transmission
electron microscopy (TEM, JEM-2100, JEOL, Japan) and
scanning electron microscopy (SEM, JSM-7001F, JEOL, Japan) were performed
to observe the shape and morphology of Au-MSN and VA@Au-MSN. The particle
sizes of Au-MSN and VA@Au-MSN were detected by dynamic light scattering
on a Malvern Zetasizer nanoZS 90 (Malvern, UK). N2 adsorption–desorption
analysis was performed and the Brunauer–Emmett–Teller
(BET) surface area was calculated. The weight loss of Au-MSN, vanillic
acid, and VA@Au-MSN was measured by thermogravimetric analysis from
25 to 800 °C at a temperature rate of 20 °C/min in a nitrogen
atmosphere at a rate of 20 mL/min.
Photothermal
Effect Measurement
In
a 1.5 mL Eppendorf tube or wound on the back of 4-week-old BALB/c
mice, 1 mL of nanoparticle dispersion in phosphate-buffered saline
(PBS, pH = 7.0) was added to the tube or 100 μL of nanoparticles
in the wound and then irradiated by a near-infrared ray (NIR) 808
nm laser for 5 min. During each 30 s interval, thermal images and
the temperature of the tube were recorded using a NIR thermal imaging
camera (Fluke, Ti400) with a laser power density of 1.0 W/cm2.
Vanillic Acid Release Assay
Vanillic
acid released from VA@Au-MSN was detected according to the reported
high-performance liquid chromatography (HPLC) method.[36] VA@Au-MSN was dispersed in PBS and maintained at 37 or
42 °C. The vanillic acid concentration in PBS at different time
points was measured by HPLC. The ratio of the vanillic acid amount
in PBS to the total amount of vanillic acid was as the cumulative
vanillic acid released from VA@Au-MSN.
Cell
Culture
The MC3T3-E1mouse calvaria-derived
cell line was purchased from the Cell Bank of the Chinese Academy
of Science (Shanghai, China). MC3T3-E1 cells were cultured in Gibco
minimum Eagle’s medium α (11900024, Thermo Fisher Scientific,
Waltham, MA) supplemented with 10% fetal bovine serum and 1% penicillin/streptomycin
at 37 °C in a humid atmosphere of 5% CO2 and 95% air.
The medium was replaced every other day.
Cytotoxicity
Test
MC3T3-E1 cells
(5 × 103 cells/cm2) were incubated with
Au-MSN and VA@Au-MSN for 24 h. The cells without any treatment were
used as a control. After half an hour of fixation using 4% paraformaldehyde,
MC3T3-E1 cells were stained with DAPI and FITC-phalloidin, respectively,
for 15 min. Then, the fluorescence in MC3T3-E1 cells was observed
using confocal laser scanning microscopy (CLSM, Leica Fluoview FV
1000, Olympus, Japan) with 405 and 562 nm laser excitation, respectively.The cytotoxicity of Au-MSN and VA@Au-MSN to MC3T3-E1 cells was
also determined by a cell counting kit-8 (CCK-8) assay. After treating
with different concentrations of Au-MSN or VA@Au-MSN (0, 0.025, 0.0625,
0.125, 0.25, and 0.5 mg/mL) for 24 h at 37 °C, 100 μL of
cell suspension (3 × 104 cells/mL) was mixed with
10 μL of CCK-8 reagent for 1 h at 37 °C. The absorbance
at 450 nm was detected. The cells without adding Au-MSN or VA@Au-MSN
were considered as a control.
Antibacterial
Assessment
S. aureus (ATCC
25923) was purchased from the American
Type Culture Collection. S. aureus (1
× 106 colony-forming units/mL) was incubated with
Au-MSN or VA@Au-MSN for 24 h at 37 °C in Mueller-Hinton Broth
medium. The bacteria treated with VA@Au-MSN with 808 nm NIR irradiation
were termed as VA@Au-MSN + NIR group. S. aureus without any treatment was used as a control. Then, S. aureus suspension was plated onto tryptic soy
agar and cultured at 37 °C for 24 h. The formative colonies on
the tryptic soy agar reflected the antibacterial potential of Au-MSN
or VA@Au-MSN against S. aureus.After 24 h of coculture, S. aureus in the control, Au-MSN, VA@Au-MSN, and VA@Au-MSN + NIR groups were
stained using the Live/Dead BacLight Bacterial Viability Kit (L-7012,
Thermo Fisher Scientific, Waltham, MA). The fluorescence images were
obtained by CLSM.
Statistical Analysis
The data was
represented as mean ± standard deviation. The statistical analysis
was performed using the Student t-test in SPSS software
(version 20.0, SPSS, Chicago, IL). The P value <
0.05 was considered a statistically significant difference.
Authors: Dongqing Yang; Asiri R Wijenayaka; Lucian B Solomon; Stephen M Pederson; David M Findlay; Stephen P Kidd; Gerald J Atkins Journal: MBio Date: 2018-04-24 Impact factor: 7.867